Bausch + Lomb Corporation announced that Karen L. Ling has been appointed to its Board of Directors (the ?Board?), effective immediately. Current director Richard De Schutter will retire from the Board effective as of the company?s 2024 Annual Meeting of Shareholders (the ?Annual Meeting?). With Ms. Ling?s appointment, the Board has been temporarily expanded to 11 members and is expected to revert to 10 directors following the Annual Meeting.

Ms. Ling is the former Executive Vice President and Chief Human Resources Officer at American International Group Inc. and, prior to that, at Allergan. She previously held senior human resources roles at Merck and Wyeth. Ms. Ling is currently a director ?

and chair of the Compensation and Human Capital Management Committee ? of iRythym Technologies and has served on the Boards of Mallinckrodt Plc and TherapeuticsMD Inc. She also serves as a member of the Advisory Committee of Galderma. Additionally, Ms. Ling is a member of the board of two nonprofits: ExpandEd Schools and the JED Foundation.

She holds a B.A. in Economics from Yale University and a J.D. from the Boston University School of Law.